Clinical Trial: Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07187063) titled 'Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer' on Aug. 15.

Brief Summary: The goal of this clinical trial is to use urine tumor DNA (utDNA) as an indicator for non-muscle invasive bladder cancer to identify patients suitable for less frequent cystoscopy surveillance.

Study Start Date: Jan. 01

Study Type: INTERVENTIONAL

Condition: Non-muscle Invasive Bladder Cancer (NMIBC)

Intervention: DIAGNOSTIC_TEST: UroAmp Test (Convergent Genomics, Inc.)

Non-invasive genomic urine test that can reliably detect, monitor, and predict the risk of urothelial cancer or its recurrence, potentially bef...